Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLUOMICS: High-Dose vs Standard-Dose Influenza Vaccine in Elderly
NCT05154383Phase 4Completed
- Sponsor
- Centre Hospitalier Annecy Genevois
- Start
- Nov 2021
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (quadrivalent, high-dose) in influenza, sponsored by Centre Hospitalier Annecy Genevois. Started Nov 2021; status: completed.
02
Drugs
influenza vaccine (quadrivalent, high-dose)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05154383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154383.